Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor Cancer Treatment With Immunotherapy”

182 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 182 results

Testing effectiveness (Phase 2)Looking for participantsNCT07462650
What this trial is testing

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdenocarcinoma of Colon
Beijing Biotech 48
Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Testing effectiveness (Phase 2)Looking for participantsNCT07502287
What this trial is testing

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-Risk Neuroblastoma+1 more
Beijing Biotech 36
Early research (Phase 1)Active Not RecruitingNCT06547957
What this trial is testing

A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
iTeos Therapeutics 55
Testing effectiveness (Phase 2)UnknownNCT00149006
What this trial is testing

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Who this might be right for
Tumors
Hadassah Medical Organization 100
Early research (Phase 1)Study completedNCT00057915
What this trial is testing

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Duke University 4
Early research (Phase 1)Looking for participantsNCT06942143
What this trial is testing

An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

Who this might be right for
SarcomaLung CancersMelanoma
Guangzhou FineImmune Biotechnology Co., LTD. 15
Early research (Phase 1)Study completedNCT02379741
What this trial is testing

ADC-1013 First-in-Human Study

Who this might be right for
NeoplasmsSolid Tumors
Alligator Bioscience AB 24
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Early research (Phase 1)Looking for participantsNCT07231458
What this trial is testing

Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies

Who this might be right for
Advanced Solid Tumors
Abalos Therapeutics GmbH 27
Testing effectiveness (Phase 2)UnknownNCT02173093
What this trial is testing

Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma

Who this might be right for
Disseminated NeuroblastomaRecurrent Neuroblastoma
University of Virginia 40
Very early researchLooking for participantsNCT06488950
What this trial is testing

TIL in Advanced Solid Tumors (DFGD)

Who this might be right for
Advanced Solid TumorTumor Infiltrating LymphocytesTreatment Side Effects+1 more
Shanghai Juncell Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT04574583
What this trial is testing

Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)

Who this might be right for
Metastatic CancerSolid Tumors
National Cancer Institute (NCI) 12
Early research (Phase 1)Looking for participantsNCT07584954
What this trial is testing

Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Solid Tumor CancerSolid Tumor Cancer Treatment With Immunotherapy
Jun Zhou 90
Testing effectiveness (Phase 2)UnknownNCT06322095
What this trial is testing

GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Patients With Advanced Solid TumorAdvanced Solid Tumor With Oncogenic Driver Mutations
Suzhou Genhouse Bio Co., Ltd. 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07389239
What this trial is testing

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

Who this might be right for
Ovarian CancerAdvanced Malignant Solid Tumor
University of Chicago 24
Testing effectiveness (Phase 2)Ended earlyNCT03721679
What this trial is testing

Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1

Who this might be right for
Solid Cancer
Oncovir, Inc. 7
Early research (Phase 1)Study completedNCT04319757
What this trial is testing

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more
Acepodia Biotech, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07589517
What this trial is testing

Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal AdenocarcinomaUnresectable Colorectal Cancer
Beijing Biotech 48
Testing effectiveness (Phase 2)Looking for participantsNCT07641023
What this trial is testing

Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdvanced/Metastatic
Beijing Biotech 60
Next Page